The NCRI Brain Group developed their new three-year strategy in December 2021 to address challenges faced in brain tumour research and to ultimately improve outcomes for brain tumour patients with currently unmet needs.
NCRI Brain Group strategic priorities:
- Produce and publish a position paper on the challenges faced in brain tumour research
- Develop a window of opportunity study, early-phase trial or basket study for glioblastoma patients
- Improve outcomes for brain tumour patients with unmet needs
- Improve outcomes for patients with poor prognosis
- Build and strengthen links with international groups and prioritise opening international studies for UK patients with rarer brain tumours
- Support and provide guidance for a broad range of research proposals across the brain cancer community